Rickettsia monacensis and Human Disease, Spain by Jado, Isabel et al.
  Emerging Infectious Diseases • www.cdc.gov/eid • Vol. 13, No. 9, September 2007  1405 
Rickettsia 
monacensis 
and Human 
Disease, Spain
Isabel Jado,* José A. Oteo,† Mikel Aldámiz,‡ 
Horacio Gil,* Raquel Escudero,* 
Valvanera Ibarra,† Joseba Portu,‡ 
Aranzazu Portillo,† María J. Lezaun,‡ 
Cristina García-Amil,* Isabel Rodríguez-Moreno,* 
and Pedro Anda*
We identiﬁ  ed Rickettsia monacensis as a cause of 
acute tickborne rickettsiosis in 2 humans. Its pathogenic 
role was assessed by culture and detection of the organism 
in patients’ blood samples. This ﬁ  nding increases the num-
ber of recognized human rickettsial pathogens and expands 
the known geographic distribution of Mediterranean spotted 
fever–like cases. 
T
ickborne rickettsioses are produced by spotted fever 
group (SFG) rickettsiae and cause an expanding spec-
trum of clinical signs. Rickettsia conorii is the etiologic 
agent of Mediterranean spotted fever (MSF) and is trans-
mitted by Rhipicephalus sanguineus. Rickettsia helvetica, 
a widespread species, is carried by Ixodes ricinus (1). Re-
cently, other SFG rickettsiae have been found in I. ricinus 
from Spain (2), Slovakia (3), and northeastern Italy (4), as 
well as in I. nipponensis from Japan (5). Subsequently, a 
new rickettsia species, R. monacensis, was isolated from 
I. ricinus from Germany (6) and  detected in Hungary (7). 
The pathogenicity of this species is unknown. It consti-
tutes a new rickettsial genotype and forms a separate clus-
ter among the SFG rickettsiae (3), close to strain Cooleyi, 
which was isolated from I. scapularis in Texas (8). I. rici-
nus is well established in areas of northern Spain (9), where 
MSF-like cases are increasingly reported.
Our study aim was to identify the SFG rickettsial spe-
cies involved in MSF-like rickettsioses in 2 patients in 
northern Spain. We report an association between R. mo-
nacensis and these rickettsioses.
The Study
Patient 1 was an 84-year-old man from La Rioja, who 
sought medical attention on June 19, 2003, 7 days after 
onset of fever (39.5ºC), general discomfort, headache, and 
joint pain. At the time of the physical examination, he had 
a nonpruritic, disseminated maculopapular rash, with no 
inoculation eschar, of the trunk and lower extremities, in-
cluding palms and soles. Other than a slightly low plate-
let count (82,000/mm3), examination ﬁ  ndings were within 
normal limits. MSF was diagnosed, and serum and deﬁ  -
brinated blood samples were taken before a course of oral 
doxycycline (100 mg/12 h for 10 d) was initiated. Three 
days later, fever and rash were gone without sequelae. Ad-
ditional serial serum samples were taken during weeks 4, 
13, and 26 after onset and reserved for serologic analysis 
(Table).
Patient 2 was a 59-year-old woman from Basque 
Country, who sought medical attention on September 20, 
2003, 4 days after onset of fever (38ºC), headache, and an 
erythematous rash, with no inoculation eschar, at the site of 
a tick bite. The patient reported a history of tick bites, most 
recently 1 week before symptom onset. Blood cell counts 
and other blood chemistry values were normal. MSF was 
diagnosed, and oral doxycycline (100 mg/12 h for 10 d) 
was prescribed. Serial serum samples were taken the day of 
the visit and weeks 4 and 6 after onset and were reserved 
for serologic analysis (Table). Deﬁ  brinated blood was also 
taken 2 days after treatment was initiated. The patient re-
covered without sequelae.
DNA was extracted with the QIAGEN Tissue kit 
(IZASA S.A., Barcelona, Spain), and an ompA-nested 
PCR was designed. The ﬁ  rst set of primers (Rr190.70p and 
Rr190.602n) have been described (10). Those used for the 
nested ampliﬁ  cation were designed in this study: Nom-
pA-F (5′-AGC GAT AAT GCT GAG TAG TAG-3′) and 
NompA-R (5′-TAT ATT TCC TAA ACC TGT ATA A-3′) 
nucleotide positions 150–170 and 576–555, respectively, 
were numbered according to Regnery et al. (10). Ampliﬁ  -
cation conditions were as described, except annealing tem-
perature was 40ºC for the second PCR and AmpliTaq Gold 
DNA Polymerase (Applied Biosystems, Branchburg, NJ, 
USA) was used. The speciﬁ  city of the method was tested 
against DNA obtained from Vero cells and Coxiella bur-
netii, and fragments of the expected sizes (532 and 427 bp) 
were obtained from different rickettsia species (data not 
shown). The amplicons obtained from blood samples were 
run in 1% low-melt agarose gels (Pronadisa, Barcelona, 
Spain), and the bands of interest were excised, puriﬁ  ed with 
QIAquick Gel Extraction kit (IZASA S.A), and sequenced 
as described (9).
A phylogenetically informative fragment of 446 bp 
of gltA was also sequenced from samples by nested PCR 
with primers designed for this study: GLTA1F (5′-GAC 
GGT GAT AAA GGA ATC TTG-3′) and GLTA1R (5′-
CAT TTC TTT CCA TTG TGC CAT C-3′) for the ﬁ  rst run, 
and GLTA2F (5′-CTA CGA ACT TAC CGC TAT TAG-
3′) and GLTA2R (5′-GAC CAA AAC CCA TTA ACC 
TAA AC-3′) for the second; nucleotide positions 279–299, 
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1011–989, 566–586, and 1298–1277, respectively, were 
numbered according to Regnery et al. (10). PCR conditions 
included annealing temperatures of 65ºC and 50ºC for the 
ﬁ  rst and second runs, respectively. The rest of the param-
eters were identical to those used above, and samples were 
subjected to 35 cycles of denaturing (20 s at 95ºC), anneal-
ing (30 s), and extension (2 min at 60ºC), with an initial 
denaturing cycle of 9 min at 95ºC.
Blood samples from each patient were cultured by us-
ing shell vial technique (11). Giménez stain and PCR, per-
formed after 7 days of incubation, conﬁ  rmed the growth of 
a Rickettsia-like organism (strain Rp-Sp1) from patient 1. 
The sequences of ompA and gltA of this isolate (GenBank 
accession nos. DQ157778 and DQ517498, respectively) 
were identical to those obtained from the blood samples 
of each patient and to that of R. monacensis (6) (GenBank 
accession nos. AF201329 and DQ100163). The sequenc-
es generated in this study were subjected to phylogenetic 
analyses as described (9) and belonged to the same clade 
as R. monacensis and other related strains that have been 
detected in I. ricinus (3,4,12) (Figure). 
In-house microimmunoﬂ  uorescence assay (IFA) ([1] 
and references therein) that used R. monacensis, R. conorii, 
R. helvetica, R. akari, and R. australis as antigens was per-
formed in serial serum samples from each patient (Table). 
The isolate Rp-Sp1 from patient 1 could not be used as an-
tigen because of poor adaptation of this isolate to culture in 
Vero cell monolayers; R. monacensis slides for IFA were 
obtained from the Department of Entomology, University 
of Minnesota, Minneapolis, MN, USA. Seroconversion 
against the 5 rickettsia species was observed from patient 
1’s second serum sample (day 30 after the onset). Patient 
2’s ﬁ  rst serum sample also had high titers against the 5 an-
tigens. Although the reactivity against the 5 rickettsial an-
tigens was similar, the titers observed were slightly higher 
against R. monacensis and R. helvetica, which are phylo-
genetically closer to each other than to the other species 
tested. However, because the serologic results may only 
loosely implicate a given rickettsia species, isolation of R. 
monacensis from patient 1 and its detection by PCR for 
both patients conﬁ  rm it as the etiologic agent.
Table. Microimmunofluorescence titers obtained with different rickettsial antigens, 2 patients, northern Spain, 2003* 
Patient Week† Rickettsia conorii R. monacensis R. helvetica R. akari R. australis
1 1 <1:40 <40 <40 <40 <40
4 1,280 2,560 2,560 1,280 640
13 1,280 1,280 1,280 1,280 1,280
26 1,280 1,280 1,280 320 320
2 1 640 2,560 2,560 640 320
4 320 1,280 1,280 320 160
6 640 1,280 1,280 320 160
*A 1-fold decrease in titer is considered not significant. 
†Week after symptom onset in which the samples were extracted. 
Figure. Neighbor-joining phylogenetic analysis based on ompA 
(panel A) and gltA (panel B). Mega 3 software (www.megasoftware.
net) was used for the calculation of pairwise distances. Numbers 
near each node represent the bootstrap values. The isolate from 
patient 1 is shown in boldface. GenBank accession no. for each 
sequence is in parentheses.Rickettsia monacensis and Human Disease, Spain
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Conclusions
We describe a new, to our knowledge, rickettsia species 
that caused human disease. R. monacensis was the etiologic 
agent of MSF-like illness in northern Spain. Strain Rp-Sp1 
was obtained from 1 patient. Because the sequences of 
ompA and gltA were identical to this rickettsia species and 
also ampliﬁ  ed from blood samples of each patient studied, 
we conclude that this rickettsia is responsible for the symp-
toms observed in these patients. Therefore, R. monacensis 
joins the list of autochthonous rickettsia species (R. conorii 
[13], R. slovaca [14], R. typhi [15]) conﬁ  rmed as human 
pathogens in Spain.
We were not able to study the vectors involved; how-
ever, each patient contracted the disease in areas where I. 
ricinus is the most prevalent tick species (9), and strains 
close to R. monacensis have been recently detected in I. 
ricinus in Spain (2,12). Thus, I. ricinus may eventually be 
shown to be the vector. Studies of R. monacensis incidence 
in autochthonous I. ricinus specimens are in progress to 
evaluate the risk of its transmission to humans.
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